Jennifer Regan serves as Executive at Accelerate Diagnostics, Inc, where they oversee executive responsibilities. Since joining the company, Jennifer Regan has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 29, 2024 involved exercising options for 4,737 shares valued at $0.
Jennifer Regan currently holds 12,631 shares of Accelerate Diagnostics, Inc (AXDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Regan has been a net neutral trader of AXDX stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Regan's most recent insider trade was on May 29, 2024, when they sold 4,737 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 7,894 |
| $N/A |
| Discretionary |